Literature DB >> 25249262

Synthesis and influenza virus inhibitory activities of carbosilane dendrimers peripherally functionalized with hemagglutinin-binding Peptide.

Ken Hatano1, Teruhiko Matsubara, Yosuke Muramatsu, Masakazu Ezure, Tetsuo Koyama, Koji Matsuoka, Ryunosuke Kuriyama, Haruka Kori, Toshinori Sato.   

Abstract

A series of carbosilane dendrimers uniformly functionalized with hemagglutinin (HA) binding peptide (sialic acid-mimic peptide, Ala-Arg-Leu-Pro-Arg) was systematically synthesized, and their anti-influenza virus activity was evaluated. The carbosilane-based peptide dendrimers, unlike sialylated dendrimers, cannot be digested by virus neuraminidases. The peptide dendrimers exhibited intriguing biological activities depending on the form of their core frame, with a dumbbell-type peptide dendrimer showing particularly strong inhibitory activities against two human influenza viruses, A/PR/8/34 (H1N1) and A/Aichi/2/68 (H3N2). The IC50 values of the dumbbell-type peptide dendrimer for both strains were 0.60 μM, the highest activity among the HA-binding peptide derivatives. The results suggest that a dumbbell-shaped carbosilane dendrimer is the most suitable core scaffold for HA-binding peptide dendrimers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25249262     DOI: 10.1021/jm5007676

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Highly sensitive detection of influenza virus by boron-doped diamond electrode terminated with sialic acid-mimic peptide.

Authors:  Teruhiko Matsubara; Michiko Ujie; Takashi Yamamoto; Miku Akahori; Yasuaki Einaga; Toshinori Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

Review 2.  Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.

Authors:  Ignacio Rodríguez-Izquierdo; Daniel Sepúlveda-Crespo; Jose María Lasso; Salvador Resino; Ma Ángeles Muñoz-Fernández
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-12

3.  Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding.

Authors:  Henry Memczak; Daniel Lauster; Parimal Kar; Santiago Di Lella; Rudolf Volkmer; Volker Knecht; Andreas Herrmann; Eva Ehrentreich-Förster; Frank F Bier; Walter F M Stöcklein
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

4.  Multivalent Peptide-Nanoparticle Conjugates for Influenza-Virus Inhibition.

Authors:  Daniel Lauster; Maria Glanz; Markus Bardua; Kai Ludwig; Markus Hellmund; Ute Hoffmann; Alf Hamann; Christoph Böttcher; Rainer Haag; Christian P R Hackenberger; Andreas Herrmann
Journal:  Angew Chem Int Ed Engl       Date:  2017-04-26       Impact factor: 15.336

Review 5.  Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases.

Authors:  Meenu Mehta; Devesh Tewari; Gaurav Gupta; Rajendra Awasthi; Harjeet Singh; Parijat Pandey; Dinesh Kumar Chellappan; Ridhima Wadhwa; Trudi Collet; Philip M Hansbro; S Rajesh Kumar; Lakshmi Thangavelu; Poonam Negi; Kamal Dua; Saurabh Satija
Journal:  Chem Biol Interact       Date:  2019-05-25       Impact factor: 5.192

Review 6.  Peptides to combat viral infectious diseases.

Authors:  Shams Al-Azzam; Yun Ding; Jinsha Liu; Priyanka Pandya; Joey Paolo Ting; Sepideh Afshar
Journal:  Peptides       Date:  2020-09-01       Impact factor: 3.750

Review 7.  Peptides and Dendrimers: How to Combat Viral and Bacterial Infections.

Authors:  Annarita Falanga; Valentina Del Genio; Stefania Galdiero
Journal:  Pharmaceutics       Date:  2021-01-14       Impact factor: 6.321

8.  Binding of Hemagglutinin and Influenza Virus to a Peptide-Conjugated Lipid Membrane.

Authors:  Teruhiko Matsubara; Rabi Shibata; Toshinori Sato
Journal:  Front Microbiol       Date:  2016-04-07       Impact factor: 5.640

Review 9.  Application of Dendrimers for the Treatment of Infectious Diseases.

Authors:  Zandile Mhlwatika; Blessing Atim Aderibigbe
Journal:  Molecules       Date:  2018-08-31       Impact factor: 4.411

Review 10.  Developments in Treatment Methodologies Using Dendrimers for Infectious Diseases.

Authors:  Nina Filipczak; Satya Siva Kishan Yalamarty; Xiang Li; Farzana Parveen; Vladimir Torchilin
Journal:  Molecules       Date:  2021-05-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.